Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity

Rituximab-refractory follicular lymphoma (FL) patients have limited options. Before the rituximab era, autologous stem cell transplantation (ASCT) was shown to improve outcomes in chemotherapy-sensitive, relapsed FL, but the impact of rituximab-sensitivity on these results is unknown. We analyzed 19...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Leuk Lymphoma
Главные авторы: Phipps, Colin, Gopal, Ajay K., Storer, Barry E., Cassaday, Ryan D., Press, Oliver W., Till, Brian G., Pagel, John M., Palanca-Wessels, Maria C., Philip, Mary, Bensinger, William I., Holmberg, Leona A., Shustov, Andrei R., Green, Damian J., Chauncey, Thomas, Maloney, David G., Libby, Edward N.
Формат: Artigo
Язык:Inglês
Опубликовано: 2014
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4269586/
https://ncbi.nlm.nih.gov/pubmed/24707941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2014.911866
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы